AU7214396A - Creatine for the protection of neural tissue - Google Patents

Creatine for the protection of neural tissue

Info

Publication number
AU7214396A
AU7214396A AU72143/96A AU7214396A AU7214396A AU 7214396 A AU7214396 A AU 7214396A AU 72143/96 A AU72143/96 A AU 72143/96A AU 7214396 A AU7214396 A AU 7214396A AU 7214396 A AU7214396 A AU 7214396A
Authority
AU
Australia
Prior art keywords
creatine
protection
neural tissue
neural
tissue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU72143/96A
Inventor
Folker Hanefeld
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Desitin Arzneimittel GmbH
Original Assignee
Desitin Arzneimittel GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Desitin Arzneimittel GmbH filed Critical Desitin Arzneimittel GmbH
Publication of AU7214396A publication Critical patent/AU7214396A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
    • A61K31/198—Alpha-aminoacids, e.g. alanine, edetic acids [EDTA]
AU72143/96A 1995-09-25 1996-09-25 Creatine for the protection of neural tissue Abandoned AU7214396A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE19537494 1995-09-25
DE1995137494 DE19537494C2 (en) 1995-09-25 1995-09-25 Creatine to protect neural tissue
PCT/EP1996/004190 WO1997011694A1 (en) 1995-09-25 1996-09-25 Creatine for the protection of neural tissue

Publications (1)

Publication Number Publication Date
AU7214396A true AU7214396A (en) 1997-04-17

Family

ID=7774348

Family Applications (1)

Application Number Title Priority Date Filing Date
AU72143/96A Abandoned AU7214396A (en) 1995-09-25 1996-09-25 Creatine for the protection of neural tissue

Country Status (3)

Country Link
AU (1) AU7214396A (en)
DE (1) DE19537494C2 (en)
WO (1) WO1997011694A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5925378A (en) * 1997-03-31 1999-07-20 Fortress Systems, L.L.C. Method for enhancing delivery and uniformity of concentration of cellular creatine
AU4954199A (en) * 1999-06-07 2000-12-28 Fortress Systems, L.L.C. Method for enhancing stable cellular creatine concentration
DE19929995B4 (en) * 1999-06-30 2004-06-03 Skw Trostberg Ag Use of creatine and / or creatine derivatives for the treatment of mental disorders in women
DE10017102A1 (en) * 2000-04-06 2001-10-11 Basf Ag Process for the manufacture of solid creatine dosage forms and dosage forms obtainable thereby
JP4406566B2 (en) 2002-03-25 2010-01-27 タカラバイオ株式会社 Method for producing cytotoxic lymphocytes
WO2005019450A1 (en) 2003-08-22 2005-03-03 Takara Bio Inc. Process for producing cytotoxic lymphocytes
WO2007020880A1 (en) 2005-08-17 2007-02-22 Takara Bio Inc. Method of producing lymphocytes

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4981691A (en) * 1980-04-14 1991-01-01 Thomas Jefferson University Oxygenated fluorocarbon nutrient solution
DE3221827A1 (en) * 1982-06-09 1983-12-15 DSO Pharmachim, Sofija BIOSTIMULATING AGENT
JPS6054320A (en) * 1983-08-31 1985-03-28 Morishita Seiyaku Kk Remedy for renal disease
IT1214598B (en) * 1985-04-17 1990-01-18 Schiapparelli Farma THERAPEUTIC USE OF PHOSPHOCREATIN.
CH666183A5 (en) * 1985-08-06 1988-07-15 Seuref Ag PHARMACEUTICAL COMPOSITION WITH CARDIAC AND METABOLIC PROTECTIVE ACTION ON THE MUSCLE ENERGY METABOLISM.
IT1191639B (en) * 1985-11-11 1988-03-23 Schiapparelli Farma PHARMACEUTICAL COMPOSITION CONTAINING PHOSPHOCREATIN AND METHOD TO PREPARE IT
US5041429A (en) * 1988-06-01 1991-08-20 Sanwa Kagaku Kenkyusho Co., Ltd. Cell activators, circulatory ameliorators and edible compositions
US5324731A (en) * 1989-02-14 1994-06-28 Amira, Inc. Method of inhibiting transformation of cells in which purine metabolic enzyme activity is elevated
US5321030A (en) * 1989-02-14 1994-06-14 Amira, Inc. Creatine analogs having antiviral activity
IT1237519B (en) * 1989-11-27 1993-06-08 USE OF GUANIDINACETIC ACID TO INDUCE AN INCREASE IN THE CREATINE MUSCLE CONTENT
CA2078712A1 (en) * 1991-09-23 1993-03-24 Bernhard Sixt Composition comprising amino acids for the prevention of hypoxic damage and a process for its preparation
DE4133366A1 (en) * 1991-10-09 1993-04-15 Nycomed Arzneimittel Gmbh Aminoacid compsn. for prevention of hypoxic cell damage - contains glycine, serine, alanine, aspartic acid or glutamic acid or mixt.
FR2684381B1 (en) * 1991-12-03 1995-05-05 Nicole Bru COMPOUNDS HAVING A PHOSPHORIC AMIDE LINK OR AN ENOL PHOSPHATE LINK FOR THEIR APPLICATION AS A THERAPEUTICALLY ACTIVE SUBSTANCE.
US5470568A (en) * 1992-02-13 1995-11-28 Arch Development Corporation Methods and compositions of a polymer (poloxamer) for cell repair
GB9215746D0 (en) * 1992-07-24 1992-09-09 Hultman Eric A method of increasing creatine supply depot
AU6097994A (en) * 1993-01-27 1994-08-15 Amira, Inc. Creatine phosphate, creatine phosphate analogs, and uses therefor
AU6165894A (en) * 1993-01-28 1994-08-15 Trustees Of The University Of Pennsylvania, The Use of creatine or analogs for the manufacture of a medicament for inhibiting tumor growth
EP2327404A1 (en) * 1994-11-08 2011-06-01 Avicena Group, Inc. Use of creatine or creatine analogs for the treatment of diseases of the nervous system

Also Published As

Publication number Publication date
WO1997011694A1 (en) 1997-04-03
DE19537494A1 (en) 1997-03-27
DE19537494C2 (en) 1997-10-02

Similar Documents

Publication Publication Date Title
AU6412796A (en) Osteosynthesis aid
AU5869796A (en) Micromechanical patch for enhancing the delivery of compound s through the skin
AU5872696A (en) Endoscope
AU3548795A (en) Benzopyranopyrazolyl derivatives for the treatment of inflammation
AU5788396A (en) Methods of inhibition or killing of cancer cells
EP0825867A4 (en) N,o-carboxymethylchitosan for prevention of surgical adhesions
AU5064196A (en) Photochemical cell
AU5859996A (en) Diaper
AU4329396A (en) Use of 3,4-diphenylchromans
AU7589996A (en) Cosmetics
AU6904896A (en) Pharmaceutical compounds
AU6250496A (en) Eyedrop applicator
EP0747346A3 (en) N-acyl-2 aryl cyclopropylmethylamine derivatives as melatonergics
AU4224096A (en) Use of phenylcyclohexylcarboxamides
AU7214396A (en) Creatine for the protection of neural tissue
AU6927894A (en) 4-amidinophenylsulphonamides for the treatment of thrombo-embolitic conditions
AU7560296A (en) Medical installation
AU6130196A (en) Cell treatment
AU5526196A (en) Compositions for the treatment of dandruff
AU5699396A (en) Compositions for the treatment of skin conditions
AU7546096A (en) Pharmaceutical compounds
AU6945596A (en) Cosmetic
AU5825896A (en) Well inhibition
AU4682896A (en) Trocar
AU5597696A (en) Treatment system